Global and China Biosimilar Testing and Development Services Market Size, Status and Forecast 2021-2027

Global and China Biosimilar Testing and Development Services Market Size, Status and Forecast 2021-2027

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biosimilar Testing and Development Services Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Effector Binding
1.2.3 ELISA
1.2.4 Kinetic Binding Assays
1.2.5 ADCC & CDC Cell-Based Assays
1.3 Market by Application
1.3.1 Global Biosimilar Testing and Development Services Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 PK assay
1.3.3 Tiered Immunogenicity testing
1.3.4 NAb assays
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Biosimilar Testing and Development Services Market Perspective (2016-2027)
2.2 Biosimilar Testing and Development Services Growth Trends by Regions
2.2.1 Biosimilar Testing and Development Services Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Biosimilar Testing and Development Services Historic Market Share by Regions (2016-2021)
2.2.3 Biosimilar Testing and Development Services Forecasted Market Size by Regions (2022-2027)
2.3 Biosimilar Testing and Development Services Industry Dynamic
2.3.1 Biosimilar Testing and Development Services Market Trends
2.3.2 Biosimilar Testing and Development Services Market Drivers
2.3.3 Biosimilar Testing and Development Services Market Challenges
2.3.4 Biosimilar Testing and Development Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biosimilar Testing and Development Services Players by Revenue
3.1.1 Global Top Biosimilar Testing and Development Services Players by Revenue (2016-2021)
3.1.2 Global Biosimilar Testing and Development Services Revenue Market Share by Players (2016-2021)
3.2 Global Biosimilar Testing and Development Services Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Biosimilar Testing and Development Services Revenue
3.4 Global Biosimilar Testing and Development Services Market Concentration Ratio
3.4.1 Global Biosimilar Testing and Development Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biosimilar Testing and Development Services Revenue in 2020
3.5 Biosimilar Testing and Development Services Key Players Head office and Area Served
3.6 Key Players Biosimilar Testing and Development Services Product Solution and Service
3.7 Date of Enter into Biosimilar Testing and Development Services Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Biosimilar Testing and Development Services Breakdown Data by Type
4.1 Global Biosimilar Testing and Development Services Historic Market Size by Type (2016-2021)
4.2 Global Biosimilar Testing and Development Services Forecasted Market Size by Type (2022-2027)
5 Biosimilar Testing and Development Services Breakdown Data by Application
5.1 Global Biosimilar Testing and Development Services Historic Market Size by Application (2016-2021)
5.2 Global Biosimilar Testing and Development Services Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Biosimilar Testing and Development Services Market Size (2016-2027)
6.2 North America Biosimilar Testing and Development Services Market Size by Type
6.2.1 North America Biosimilar Testing and Development Services Market Size by Type (2016-2021)
6.2.2 North America Biosimilar Testing and Development Services Market Size by Type (2022-2027)
6.2.3 North America Biosimilar Testing and Development Services Market Size by Type (2016-2027)
6.3 North America Biosimilar Testing and Development Services Market Size by Application
6.3.1 North America Biosimilar Testing and Development Services Market Size by Application (2016-2021)
6.3.2 North America Biosimilar Testing and Development Services Market Size by Application (2022-2027)
6.3.3 North America Biosimilar Testing and Development Services Market Size by Application (2016-2027)
6.4 North America Biosimilar Testing and Development Services Market Size by Country
6.4.1 North America Biosimilar Testing and Development Services Market Size by Country (2016-2021)
6.4.2 North America Biosimilar Testing and Development Services Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Biosimilar Testing and Development Services Market Size (2016-2027)
7.2 Europe Biosimilar Testing and Development Services Market Size by Type
7.2.1 Europe Biosimilar Testing and Development Services Market Size by Type (2016-2021)
7.2.2 Europe Biosimilar Testing and Development Services Market Size by Type (2022-2027)
7.2.3 Europe Biosimilar Testing and Development Services Market Size by Type (2016-2027)
7.3 Europe Biosimilar Testing and Development Services Market Size by Application
7.3.1 Europe Biosimilar Testing and Development Services Market Size by Application (2016-2021)
7.3.2 Europe Biosimilar Testing and Development Services Market Size by Application (2022-2027)
7.3.3 Europe Biosimilar Testing and Development Services Market Size by Application (2016-2027)
7.4 Europe Biosimilar Testing and Development Services Market Size by Country
7.4.1 Europe Biosimilar Testing and Development Services Market Size by Country (2016-2021)
7.4.2 Europe Biosimilar Testing and Development Services Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Biosimilar Testing and Development Services Market Size (2016-2027)
8.2 Asia-Pacific Biosimilar Testing and Development Services Market Size by Type
8.2.1 Asia-Pacific Biosimilar Testing and Development Services Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Biosimilar Testing and Development Services Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Biosimilar Testing and Development Services Market Size by Type (2016-2027)
8.3 Asia-Pacific Biosimilar Testing and Development Services Market Size by Application
8.3.1 Asia-Pacific Biosimilar Testing and Development Services Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Biosimilar Testing and Development Services Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Biosimilar Testing and Development Services Market Size by Application (2016-2027)
8.4 Asia-Pacific Biosimilar Testing and Development Services Market Size by Region
8.4.1 Asia-Pacific Biosimilar Testing and Development Services Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Biosimilar Testing and Development Services Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Biosimilar Testing and Development Services Market Size (2016-2027)
9.2 Latin America Biosimilar Testing and Development Services Market Size by Type
9.2.1 Latin America Biosimilar Testing and Development Services Market Size by Type (2016-2021)
9.2.2 Latin America Biosimilar Testing and Development Services Market Size by Type (2022-2027)
9.2.3 Latin America Biosimilar Testing and Development Services Market Size by Type (2016-2027)
9.3 Latin America Biosimilar Testing and Development Services Market Size by Application
9.3.1 Latin America Biosimilar Testing and Development Services Market Size by Application (2016-2021)
9.3.2 Latin America Biosimilar Testing and Development Services Market Size by Application (2022-2027)
9.3.3 Latin America Biosimilar Testing and Development Services Market Size by Application (2016-2027)
9.4 Latin America Biosimilar Testing and Development Services Market Size by Country
9.4.1 Latin America Biosimilar Testing and Development Services Market Size by Country (2016-2021)
9.4.2 Latin America Biosimilar Testing and Development Services Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Biosimilar Testing and Development Services Market Size (2016-2027)
10.2 Middle East & Africa Biosimilar Testing and Development Services Market Size by Type
10.2.1 Middle East & Africa Biosimilar Testing and Development Services Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Biosimilar Testing and Development Services Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Biosimilar Testing and Development Services Market Size by Type (2016-2027)
10.3 Middle East & Africa Biosimilar Testing and Development Services Market Size by Application
10.3.1 Middle East & Africa Biosimilar Testing and Development Services Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Biosimilar Testing and Development Services Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Biosimilar Testing and Development Services Market Size by Application (2016-2027)
10.4 Middle East & Africa Biosimilar Testing and Development Services Market Size by Country
10.4.1 Middle East & Africa Biosimilar Testing and Development Services Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Biosimilar Testing and Development Services Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Eurofins Scientific
11.1.1 Eurofins Scientific Company Details
11.1.2 Eurofins Scientific Business Overview
11.1.3 Eurofins Scientific Biosimilar Testing and Development Services Introduction
11.1.4 Eurofins Scientific Revenue in Biosimilar Testing and Development Services Business (2016-2021)
11.1.5 Eurofins Scientific Recent Development
11.2 SGS
11.2.1 SGS Company Details
11.2.2 SGS Business Overview
11.2.3 SGS Biosimilar Testing and Development Services Introduction
11.2.4 SGS Revenue in Biosimilar Testing and Development Services Business (2016-2021)
11.2.5 SGS Recent Development
11.3 Charles River Laboratories
11.3.1 Charles River Laboratories Company Details
11.3.2 Charles River Laboratories Business Overview
11.3.3 Charles River Laboratories Biosimilar Testing and Development Services Introduction
11.3.4 Charles River Laboratories Revenue in Biosimilar Testing and Development Services Business (2016-2021)
11.3.5 Charles River Laboratories Recent Development
11.4 Pharmaceutical Product Development
11.4.1 Pharmaceutical Product Development Company Details
11.4.2 Pharmaceutical Product Development Business Overview
11.4.3 Pharmaceutical Product Development Biosimilar Testing and Development Services Introduction
11.4.4 Pharmaceutical Product Development Revenue in Biosimilar Testing and Development Services Business (2016-2021)
11.4.5 Pharmaceutical Product Development Recent Development
11.5 Exova
11.5.1 Exova Company Details
11.5.2 Exova Business Overview
11.5.3 Exova Biosimilar Testing and Development Services Introduction
11.5.4 Exova Revenue in Biosimilar Testing and Development Services Business (2016-2021)
11.5.5 Exova Recent Development
11.6 Source BioScience
11.6.1 Source BioScience Company Details
11.6.2 Source BioScience Business Overview
11.6.3 Source BioScience Biosimilar Testing and Development Services Introduction
11.6.4 Source BioScience Revenue in Biosimilar Testing and Development Services Business (2016-2021)
11.6.5 Source BioScience Recent Development
11.7 Intertek Group
11.7.1 Intertek Group Company Details
11.7.2 Intertek Group Business Overview
11.7.3 Intertek Group Biosimilar Testing and Development Services Introduction
11.7.4 Intertek Group Revenue in Biosimilar Testing and Development Services Business (2016-2021)
11.7.5 Intertek Group Recent Development
11.8 Medistri
11.8.1 Medistri Company Details
11.8.2 Medistri Business Overview
11.8.3 Medistri Biosimilar Testing and Development Services Introduction
11.8.4 Medistri Revenue in Biosimilar Testing and Development Services Business (2016-2021)
11.8.5 Medistri Recent Development
11.9 Pace Analytical Services
11.9.1 Pace Analytical Services Company Details
11.9.2 Pace Analytical Services Business Overview
11.9.3 Pace Analytical Services Biosimilar Testing and Development Services Introduction
11.9.4 Pace Analytical Services Revenue in Biosimilar Testing and Development Services Business (2016-2021)
11.9.5 Pace Analytical Services Recent Development
11.10 Sigma-Aldrich
11.10.1 Sigma-Aldrich Company Details
11.10.2 Sigma-Aldrich Business Overview
11.10.3 Sigma-Aldrich Biosimilar Testing and Development Services Introduction
11.10.4 Sigma-Aldrich Revenue in Biosimilar Testing and Development Services Business (2016-2021)
11.10.5 Sigma-Aldrich Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Biosimilar Testing and Development Services Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Effector Binding
Table 3. Key Players of ELISA
Table 4. Key Players of Kinetic Binding Assays
Table 5. Key Players of ADCC & CDC Cell-Based Assays
Table 6. Global Biosimilar Testing and Development Services Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Biosimilar Testing and Development Services Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Biosimilar Testing and Development Services Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Biosimilar Testing and Development Services Market Share by Regions (2016-2021)
Table 10. Global Biosimilar Testing and Development Services Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Biosimilar Testing and Development Services Market Share by Regions (2022-2027)
Table 12. Biosimilar Testing and Development Services Market Trends
Table 13. Biosimilar Testing and Development Services Market Drivers
Table 14. Biosimilar Testing and Development Services Market Challenges
Table 15. Biosimilar Testing and Development Services Market Restraints
Table 16. Global Biosimilar Testing and Development Services Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Biosimilar Testing and Development Services Market Share by Players (2016-2021)
Table 18. Global Top Biosimilar Testing and Development Services Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biosimilar Testing and Development Services as of 2020)
Table 19. Ranking of Global Top Biosimilar Testing and Development Services Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Biosimilar Testing and Development Services Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Biosimilar Testing and Development Services Product Solution and Service
Table 23. Date of Enter into Biosimilar Testing and Development Services Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Biosimilar Testing and Development Services Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Biosimilar Testing and Development Services Revenue Market Share by Type (2016-2021)
Table 27. Global Biosimilar Testing and Development Services Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Biosimilar Testing and Development Services Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Biosimilar Testing and Development Services Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Biosimilar Testing and Development Services Revenue Market Share by Application (2016-2021)
Table 31. Global Biosimilar Testing and Development Services Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Biosimilar Testing and Development Services Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Biosimilar Testing and Development Services Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Biosimilar Testing and Development Services Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Biosimilar Testing and Development Services Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Biosimilar Testing and Development Services Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Biosimilar Testing and Development Services Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Biosimilar Testing and Development Services Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Biosimilar Testing and Development Services Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Biosimilar Testing and Development Services Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Biosimilar Testing and Development Services Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Biosimilar Testing and Development Services Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Biosimilar Testing and Development Services Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Biosimilar Testing and Development Services Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Biosimilar Testing and Development Services Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Biosimilar Testing and Development Services Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Biosimilar Testing and Development Services Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Biosimilar Testing and Development Services Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Biosimilar Testing and Development Services Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Biosimilar Testing and Development Services Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Biosimilar Testing and Development Services Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Biosimilar Testing and Development Services Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Biosimilar Testing and Development Services Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Biosimilar Testing and Development Services Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Biosimilar Testing and Development Services Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Biosimilar Testing and Development Services Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Biosimilar Testing and Development Services Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Biosimilar Testing and Development Services Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Biosimilar Testing and Development Services Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Biosimilar Testing and Development Services Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Biosimilar Testing and Development Services Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Biosimilar Testing and Development Services Market Size by Country (2022-2027) & (US$ Million)
Table 63. Eurofins Scientific Company Details
Table 64. Eurofins Scientific Business Overview
Table 65. Eurofins Scientific Biosimilar Testing and Development Services Product
Table 66. Eurofins Scientific Revenue in Biosimilar Testing and Development Services Business (2016-2021) & (US$ Million)
Table 67. Eurofins Scientific Recent Development
Table 68. SGS Company Details
Table 69. SGS Business Overview
Table 70. SGS Biosimilar Testing and Development Services Product
Table 71. SGS Revenue in Biosimilar Testing and Development Services Business (2016-2021) & (US$ Million)
Table 72. SGS Recent Development
Table 73. Charles River Laboratories Company Details
Table 74. Charles River Laboratories Business Overview
Table 75. Charles River Laboratories Biosimilar Testing and Development Services Product
Table 76. Charles River Laboratories Revenue in Biosimilar Testing and Development Services Business (2016-2021) & (US$ Million)
Table 77. Charles River Laboratories Recent Development
Table 78. Pharmaceutical Product Development Company Details
Table 79. Pharmaceutical Product Development Business Overview
Table 80. Pharmaceutical Product Development Biosimilar Testing and Development Services Product
Table 81. Pharmaceutical Product Development Revenue in Biosimilar Testing and Development Services Business (2016-2021) & (US$ Million)
Table 82. Pharmaceutical Product Development Recent Development
Table 83. Exova Company Details
Table 84. Exova Business Overview
Table 85. Exova Biosimilar Testing and Development Services Product
Table 86. Exova Revenue in Biosimilar Testing and Development Services Business (2016-2021) & (US$ Million)
Table 87. Exova Recent Development
Table 88. Source BioScience Company Details
Table 89. Source BioScience Business Overview
Table 90. Source BioScience Biosimilar Testing and Development Services Product
Table 91. Source BioScience Revenue in Biosimilar Testing and Development Services Business (2016-2021) & (US$ Million)
Table 92. Source BioScience Recent Development
Table 93. Intertek Group Company Details
Table 94. Intertek Group Business Overview
Table 95. Intertek Group Biosimilar Testing and Development Services Product
Table 96. Intertek Group Revenue in Biosimilar Testing and Development Services Business (2016-2021) & (US$ Million)
Table 97. Intertek Group Recent Development
Table 98. Medistri Company Details
Table 99. Medistri Business Overview
Table 100. Medistri Revenue in Biosimilar Testing and Development Services Business (2016-2021) & (US$ Million)
Table 101. Medistri Recent Development
Table 102. Pace Analytical Services Company Details
Table 103. Pace Analytical Services Business Overview
Table 104. Pace Analytical Services Biosimilar Testing and Development Services Product
Table 105. Pace Analytical Services Revenue in Biosimilar Testing and Development Services Business (2016-2021) & (US$ Million)
Table 106. Pace Analytical Services Recent Development
Table 107. Sigma-Aldrich Company Details
Table 108. Sigma-Aldrich Business Overview
Table 109. Sigma-Aldrich Biosimilar Testing and Development Services Product
Table 110. Sigma-Aldrich Revenue in Biosimilar Testing and Development Services Business (2016-2021) & (US$ Million)
Table 111. Sigma-Aldrich Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Biosimilar Testing and Development Services Market Share by Type: 2020 VS 2027
Figure 2. Effector Binding Features
Figure 3. ELISA Features
Figure 4. Kinetic Binding Assays Features
Figure 5. ADCC & CDC Cell-Based Assays Features
Figure 6. Global Biosimilar Testing and Development Services Market Share by Application: 2020 VS 2027
Figure 7. PK assay Case Studies
Figure 8. Tiered Immunogenicity testing Case Studies
Figure 9. NAb assays Case Studies
Figure 10. Biosimilar Testing and Development Services Report Years Considered
Figure 11. Global Biosimilar Testing and Development Services Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Biosimilar Testing and Development Services Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Biosimilar Testing and Development Services Market Share by Regions: 2020 VS 2027
Figure 14. Global Biosimilar Testing and Development Services Market Share by Regions (2022-2027)
Figure 15. Global Biosimilar Testing and Development Services Market Share by Players in 2020
Figure 16. Global Top Biosimilar Testing and Development Services Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biosimilar Testing and Development Services as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Biosimilar Testing and Development Services Revenue in 2020
Figure 18. Global Biosimilar Testing and Development Services Revenue Market Share by Type (2016-2021)
Figure 19. Global Biosimilar Testing and Development Services Revenue Market Share by Type (2022-2027)
Figure 20. North America Biosimilar Testing and Development Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Biosimilar Testing and Development Services Market Share by Type (2016-2027)
Figure 22. North America Biosimilar Testing and Development Services Market Share by Application (2016-2027)
Figure 23. North America Biosimilar Testing and Development Services Market Share by Country (2016-2027)
Figure 24. United States Biosimilar Testing and Development Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Biosimilar Testing and Development Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Biosimilar Testing and Development Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Biosimilar Testing and Development Services Market Share by Type (2016-2027)
Figure 28. Europe Biosimilar Testing and Development Services Market Share by Application (2016-2027)
Figure 29. Europe Biosimilar Testing and Development Services Market Share by Country (2016-2027)
Figure 30. Germany Biosimilar Testing and Development Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Biosimilar Testing and Development Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Biosimilar Testing and Development Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Biosimilar Testing and Development Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Biosimilar Testing and Development Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Biosimilar Testing and Development Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Biosimilar Testing and Development Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Biosimilar Testing and Development Services Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Biosimilar Testing and Development Services Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Biosimilar Testing and Development Services Market Share by Region (2016-2027)
Figure 40. China Biosimilar Testing and Development Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Biosimilar Testing and Development Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Biosimilar Testing and Development Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Biosimilar Testing and Development Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Biosimilar Testing and Development Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Biosimilar Testing and Development Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Biosimilar Testing and Development Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Biosimilar Testing and Development Services Market Share by Type (2016-2027)
Figure 48. Latin America Biosimilar Testing and Development Services Market Share by Application (2016-2027)
Figure 49. Latin America Biosimilar Testing and Development Services Market Share by Country (2016-2027)
Figure 50. Mexico Biosimilar Testing and Development Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Biosimilar Testing and Development Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Biosimilar Testing and Development Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Biosimilar Testing and Development Services Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Biosimilar Testing and Development Services Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Biosimilar Testing and Development Services Market Share by Country (2016-2027)
Figure 56. Turkey Biosimilar Testing and Development Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Biosimilar Testing and Development Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Biosimilar Testing and Development Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Eurofins Scientific Revenue Growth Rate in Biosimilar Testing and Development Services Business (2016-2021)
Figure 60. SGS Revenue Growth Rate in Biosimilar Testing and Development Services Business (2016-2021)
Figure 61. Charles River Laboratories Revenue Growth Rate in Biosimilar Testing and Development Services Business (2016-2021)
Figure 62. Pharmaceutical Product Development Revenue Growth Rate in Biosimilar Testing and Development Services Business (2016-2021)
Figure 63. Exova Revenue Growth Rate in Biosimilar Testing and Development Services Business (2016-2021)
Figure 64. Source BioScience Revenue Growth Rate in Biosimilar Testing and Development Services Business (2016-2021)
Figure 65. Intertek Group Revenue Growth Rate in Biosimilar Testing and Development Services Business (2016-2021)
Figure 66. Medistri Revenue Growth Rate in Biosimilar Testing and Development Services Business (2016-2021)
Figure 67. Pace Analytical Services Revenue Growth Rate in Biosimilar Testing and Development Services Business (2016-2021)
Figure 68. Sigma-Aldrich Revenue Growth Rate in Biosimilar Testing and Development Services Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118

The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......

Global Non-imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90

The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......

Global PCR Equipment Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77

The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......

Global Disposable Sterile Syringes and Needles Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109

The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......

Global Orthopaedic Power Tools Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......

Global Cerebrospinal Fluid Management Devices Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......

Global CAD & CAM Milling Burs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......

Global Artificial Teeth Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98

The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs